Surufatinib — a novel oral agent for neuroendocrine tumours

Authors: Anna Koumarianou, Gregory Kaltsas

Published: 2020-10-30

DOI: 10.1038/s41574-020-00439-0

Source: Full article

Abstract

No abstract found.